Zeolite

1. What conditions has Zeolite been studied for?

• Environmental/water treatment (not a human “condition,” but a major research area): removal of antibiotics and antibiotic resistance genes (ARGs) in constructed wetlands; removal of diverse wastewater contaminants via adsorption/ion exchange/photocatalysis; removal of pharmaceuticals from water (e.g., colistin, fluoxetine, amoxicillin, ethinylestradiol).

• Hemorrhage control (trauma/surgical bleeding): zeolite used as part of a composite hemostatic gauze (with kaolin) to accelerate clotting in an animal injury model.

• Drug delivery / pharmaceutical applications: zeolite-based nanoparticles explored as drug carriers (controlled/targeted release) and as platforms in biomedical applications (review mentions antidiarrheal, antitumor, antibacterial, MRI contrast agent roles, and notes clinical trials exist, without details in the abstract).

• Veterinary/poultry production and gut health (animal studies): zeolite as a feed additive and/or bedding additive to influence productivity, microbiome/pathogen load, and intestinal/immune-related gene expression in broilers; laying hen performance and egg quality; pathogen suppression as an alternative to antibiotics.

• Agronomy/soil and composting: co-composting chicken manure/straw with zeolite to affect nitrogen conversion (ammonia-related outcomes implied but truncated); soil remediation contexts including heavy metal (cadmium) immobilization (mentioned in an abstract snippet about biochar + zeolite).

• High-sulfate wastewater bioremediation (microbial process support): zeolite used as a “biostimulant” to enhance microbial sulfate reduction by providing microbial attachment sites; synergy with maifanite reported.

• “Detoxification”/human health claims (clinoptilolite): a review-style abstract notes clinoptilolite has been widely studied in veterinary and human medicine and mentions “detoxification properties,” but provides no specific conditions or outcomes in the excerpt provided.

2. Does it work in treating those conditions? Summarize the evidence.

• Hemorrhage control: In a rabbit femoral artery injury model, a kaolin-modified zeolite gauze reduced blood loss by 75% and shortened hemostasis time by 33% compared with a “combat gauze” comparator, and it reportedly had no heat release problem and nearly zero particle shedding (animal preclinical evidence; not a human clinical trial in the abstract).

• Removal of pharmaceuticals from water: Synthetic zeolite (NaP1_FA) and a zeolite-carbon composite (NaP1_C) derived from fly ash achieved >90% removal within 2 minutes for colistin, fluoxetine, amoxicillin, and ethinylestradiol in batch adsorption experiments (strong bench-scale performance; not a health treatment, but supports environmental remediation efficacy).

• Antibiotics/ARGs in constructed wetlands: A review concludes zeolite substrates generally show better removal of antibiotics and intracellular ARGs than gravel, attributed to enhanced adsorption, filtration, and biodegradation processes (comparative performance summarized at review level; magnitude depends on system design and is not quantified in the excerpt).

• Poultry gut microbiome/pathogen suppression: In a study testing 4% feed additives, zeolite did not significantly alter overall richness/diversity of the intestinal bacterial community but was associated with reduction in Proteobacteria and “milder” reductions in some potential pathogens compared with bentonite (suggestive evidence for pathogen-load modulation; not direct evidence of improved clinical outcomes in animals or humans from the excerpt).

• High-sulfate wastewater microbial reduction: Zeolite increased microbial growth mainly by providing attachment sites; combined with maifanite showed a synergistic effect with higher sulfate reduction rates than either alone (process-level evidence; not a human treatment).

• Human “detoxification”/medical treatment claims (clinoptilolite): The provided abstract fragment asserts positive health effects including “detoxification,” but does not provide specific clinical endpoints, effect sizes, or trial details in the excerpt. Based on the text provided here alone, efficacy for human detoxification or disease treatment cannot be confirmed.

Overall, the strongest “treatment-like” evidence in the provided abstracts is for topical hemostasis (animal model). Many other findings relate to environmental remediation or animal production, which do not directly establish human therapeutic benefit.

3. What health benefits does it have?

• Potential emergency bleeding control (topical device/material use): Zeolite (in a kaolin-zeolite composite gauze) enhanced coagulation cascade activity (FXII activation via kaolin; assembly of FXa/FVa and thrombin generation supported by zeolite surface) and improved hemostatic outcomes in an animal model.

• Potential role as a drug delivery platform (research-stage): A review describes zeolite-based nanoparticles integrated into polymers enabling controlled release, improved drug stability, and targeted delivery; it also notes biomedical applications (antidiarrheal, antitumor, antibacterial, MRI contrast agents) and mentions clinical trials exist, but the excerpt does not provide outcomes.

• Indirect public health/environmental benefits: Multiple abstracts emphasize zeolite’s adsorption/ion-exchange capacity for removing contaminants (antibiotics, pharmaceuticals, VOCs, dyes, radioactive waste) from water and wastewater, which could reduce environmental exposure risks (this is not the same as a direct supplement benefit).

• Animal health/production-related benefits (veterinary context): Evidence suggests zeolite in feed may reduce certain potentially pathogenic taxa without broadly reducing microbiome diversity, and zeolite is discussed as a non-toxic silicate mineral with potential biosafety/hygiene benefits in poultry production (direct performance outcomes are not fully shown in the provided excerpts).

Important limitation: the abstracts provided contain limited direct human clinical evidence for oral zeolite supplements; many “benefits” described are mechanistic, preclinical, veterinary, or environmental.

4. Does it have any downsides or side effects?

• Nanoparticle safety concerns (theoretical/under evaluation): The nanoparticle review explicitly notes the need to address potential carcinogenicity, environmental impact, and risk assessment for zeolite-based nanoparticles (this indicates uncertainty and the need for safety evaluation rather than proving harm).

• Microbiome shifts (animal data): Zeolite feed supplementation in poultry was associated with reductions in some bacterial groups (e.g., reduced Proteobacteria). While this may be beneficial in some contexts, it also indicates zeolite can alter gut microbial composition (the excerpt does not report adverse clinical effects).

• Product-specific risks (implied by hemostatic materials literature): The hemostatic gauze abstract highlights “no heat release problem” and “nearly zero particle shedding,” implying these are known safety concerns for some inorganic hemostatic gauzes; the described kaolin-zeolite gauze was designed to mitigate them.

• Evidence gaps for oral supplementation safety: The provided clinoptilolite “detoxification” excerpt does not include adverse event data, dosing, duration, or contamination testing. Without those details, side-effect risk for supplements (including potential contamination with heavy metals depending on source) cannot be assessed from these abstracts alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The provided abstracts do not report pharmacogenomic analyses, genotype-stratified outcomes, or gene–zeolite interactions in humans.

• No direct evidence in these excerpts that zeolite’s effects (as a supplement, hemostatic material, or drug-delivery platform) are beneficial or harmful for specific genetic variants.

• One poultry study mentions assessing expression of genes related to intestinal tightness, defense, and immune response, but this is gene expression (transcript changes) in animals, not inherited human genetic variation affecting response.

Conclusion: Based on the abstracts provided, there is insufficient evidence to make pharmacogenomic recommendations for zeolite.

References

1. Critical Review on Zeolite Clinoptilolite Safety and Medical Applications
   Sandra Kraljević Pavelić, Jasmina Simović Medica, Darko Gumbarević, Ana Filošević, Nataša Pržulj, Krešimir Pavelić (2018) - Frontiers in pharmacology
2. Contribution of zeolite to nitrogen retention in chicken manure and straw compost: Reduction of NH
   Bing Wang, Peng Zhang, Xu Guo, Xu Bao, Junjie Tian, Guomin Li, Jian Zhang (2024) - Bioresource technology
3. Roles of substrates in removing antibiotics and antibiotic resistance genes in constructed wetlands: A review.
   Erping Cui, Zhenchao Zhou, Feng Gao, Hong Chen, Jianan Li (2023) - The Science of the total environment
4. Exploring zeolite-based composites in adsorption and photocatalysis for toxic wastewater treatment: Preparation, mechanisms, and future perspectives.
   Iqra Liaquat, Ruba Munir, Naseer Ahmed Abbasi, Bushra Sadia, Amna Muneer, Fazila Younas, Muhammad Fahad Sardar, Muhammad Zahid, Saima Noreen (2024) - Environmental pollution (Barking, Essex : 1987)
5. Zeolite-based nanoparticles drug delivery systems in modern pharmaceutical research and environmental remediation.
   Tosha Pandya, Shruti Patel, Mangesh Kulkarni, Yash Raj Singh, Akruti Khodakiya, Sankha Bhattacharya, Bhupendra G Prajapati (2024) - Heliyon
6. Zeolite Clinoptilolite: Therapeutic Virtues of an Ancient Mineral.
   Andrea Mastinu, Amit Kumar, Giuseppina Maccarinelli, Sara Anna Bonini, Marika Premoli, Francesca Aria, Alessandra Gianoncelli, Maurizio Memo (2019) - Molecules (Basel, Switzerland)
7. Synergistic Procoagulant Mechanism and Application of Kaolin-Zeolite Composite Hemostat for Effective Hemorrhage Control.
   Chenchen Wang, Chaojie Shi, Jianrong Huang, Xuefei Wei, Yifeng Shi, Liping Xiao, Jie Fan (2024) - ACS applied materials & interfaces
8. Using Zeolite Materials to Remove Pharmaceuticals from Water.
   Tomasz Bajda, Agnieszka Grela, Justyna Pamuła, Joanna Kuc, Agnieszka Klimek, Jakub Matusik, Wojciech Franus, Santhana Krishna Kumar Alagarsamy, Tomasz Danek, Paweł Gara (2024) - Materials (Basel, Switzerland)
9. Biochar, Bentonite and Zeolite Supplemented Feeding of Layer Chickens Alters Intestinal Microbiota and Reduces Campylobacter Load.
   Tanka P Prasai, Kerry B Walsh, Surya P Bhattarai, David J Midmore, Thi T H Van, Robert J Moore, Dragana Stanley (2016) - PloS one
10. Combined application of biochar and nano-zeolite enhanced cadmium immobilization and promote the growth of Pak Choi in cadmium contaminated soil.
    Shanshan Feng, Peng Zhang, Yanmei Hu, Feng Jin, Yuqing Liu, Shixin Cai, Zijie Song, Xing Zhang, Tcyganova Nadezhda, Zhiling Guo, Iseult Lynch, Xiuli Dang (2022) - NanoImpact
11. Performance and economic efficiency of laying hens in response to adding zeolite to feed and litter.
    Ahmed I Elsherbeni, Islam M Youssef, Reda E Hamouda, Mahmoud Kamal, Gaafar M El-Gendi, Osama H El-Garhi, Haifa E Alfassam, Hassan A Rudayni, Ahmed A Allam, Mahmoud Moustafa, Mohammed O Alshaharn, Mohamed S El Kholy (2024) - Poultry science
12. The mechanism of microbial sulfate reduction in high concentration sulfate wastewater enhanced by maifanite.
    Chaorui Zhao, Nan Chen, Tong Liu, Wenjun Liu, Wesmanegda Elisee Dipama, Chuanping Feng (2024) - Water research
13. Confinement Effects in Zeolite-Confined Noble Metals.
    Si-Ming Wu, Xiao-Yu Yang, Christoph Janiak (2019) - Angewandte Chemie (International ed. in English)
14. Effect of Zeolite Supplementation on Gene Expression in the Intestinal Mucosa in the Context of Immunosafety Support in Poultry.
    Aleksandra Dunislawska, Jakub Biesek, Mirosław Banaszak, Maria Siwek, Marek Adamski (2022) - Genes
15. Design and characterization of chitosan/zeolite composite films--Effect of zeolite type and zeolite dose on the film properties.
    Gustavo P Barbosa, Henrique S Debone, Patrícia Severino, Eliana B Souto, Classius F da Silva (2016) - Materials science & engineering. C, Materials for biological applications
16. Design and development of biodegradable POSS-PCL-Zeolite (β) nano-scaffold for potential applications in bone regeneration.
    Leyla Bagheri, Davoud Jafari-Gharabaghlou, Hasan Valizadeh, Abolfazl Barzegari, Nosratollah Zarghami (2023) - Journal of biomaterials science. Polymer edition
17. Development and characterization of a zeolite based drug delivery system: Application to cannabidiol oral delivery.
    Fouad Dernaika, Layal Halawy, Joseph Zeaiter, Sara Kawrani, Dima Mroue, Anthony Lteif, Sima Kourani, Mohamed Mehanna, Celine Abboud, Mohamad Mroueh, Aline Milane (2024) - Heliyon
18. One-dimensional intergrowths in two-dimensional zeolite nanosheets and their effect on ultra-selective transport.
    Prashant Kumar, Dae Woo Kim, Neel Rangnekar, Hao Xu, Evgenii O Fetisov, Supriya Ghosh, Han Zhang, Qiang Xiao, Meera Shete, J Ilja Siepmann, Traian Dumitrica, Benjamin McCool, Michael Tsapatsis, K Andre Mkhoyan (2020) - Nature materials
19. The effect of oral administration of zeolite on the energy metabolism and reproductive health of Romanian spotted breed in advanced gestation and post partum period.
    O V Giurgiu, D I Berean, A Ionescu, M S Ciupe, C R Cimpean, C I Radu, D G Bitica, S Bogdan, M L Bogdan (2024) - Veterinary and animal science
20. Water-Induced Micro-Hydrophobic Effect Regulates Benzene Methylation in Zeolite.
    Chao Wang, Yueying Chu, Danfeng Xiong, Haifeng Wang, Min Hu, Qiang Wang, Jun Xu, Feng Deng (2024) - Angewandte Chemie (International ed. in English)